We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+3.76%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$910M
AUM Growth
-$281M
Cap. Flow
-$283M
Cap. Flow %
-31.16%
Top 10 Hldgs %
40.89%
Holding
141
New
25
Increased
18
Reduced
31
Closed
51

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$27.6M
2
AMZN icon
Amazon
AMZN
+$13.8M
3
FIVN icon
FIVE9
FIVN
+$12.7M
4
SNY icon
Sanofi
SNY
+$11.9M
5
S icon
SentinelOne
S
+$11.7M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$47.9M
2
PFE icon
Pfizer
PFE
+$43.5M
3
ABBV icon
AbbVie
ABBV
+$15.6M
4
AZN icon
AstraZeneca
AZN
+$13.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 68.66%
2 Technology 9.03%
3 Consumer Discretionary 4.71%
4 Communication Services 2.8%
5 Industrials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$443B
$62.9M 6.91%
464,194
-132,100
-22% -$15.6M
AZN icon
2
AstraZeneca
AZN
$263B
$61.5M 6.76%
527,734
-118,100
-18% -$13.9M
SNY icon
3
Sanofi
SNY
$103B
$54.3M 5.97%
1,083,400
+240,000
+28% +$11.9M
LLY icon
4
Eli Lilly
LLY
$1.02T
$44.1M 4.85%
159,695
-188,800
-54% -$47.9M
MRK icon
5
Merck
MRK
$322B
$26.6M 2.92%
+346,423
New +$27.6M
JNJ icon
6
Johnson & Johnson
JNJ
$618B
$26.5M 2.92%
155,123
-83,825
-35% -$13.7M
SNDX icon
7
Syndax Pharmaceuticals
SNDX
$1.69B
$25.8M 2.83%
1,176,585
+425,982
+57% +$7.87M
XBI icon
8
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$24.6M 2.71%
+220,000
New +$26.5M
FIVN icon
9
CALL
FIVE9
FIVN
$2.11B
$24.5M 2.7%
+178,500
New +$26.4M
SWTX
10
DELISTED
SpringWorks Therapeutics
SWTX
$21.2M 2.33%
342,566
+94,649
+38% +$6.26M
KYMR icon
11
Kymera Therapeutics
KYMR
$8.51B
$20.2M 2.22%
318,667
-40,593
-11% -$2.36M
BMRN icon
12
BioMarin Pharmaceuticals
BMRN
$11.6B
$19.2M 2.11%
216,977
+67,960
+46% +$5.61M
MSFT icon
13
Microsoft
MSFT
$3.45T
$17M 1.87%
50,536
-17,000
-25% -$5.51M
GNRC icon
14
Generac Holdings
GNRC
$11.6B
$14.8M 1.63%
42,057
-28,956
-41% -$12M
AMZN icon
15
Amazon
AMZN
$2.92T
$14M 1.54%
84,000
+80,780
+2,509% +$13.8M
META icon
16
Meta Platforms (Facebook)
META
$1.42T
$14M 1.54%
41,622
+7,222
+21% +$2.4M
PFE icon
17
Pfizer
PFE
$143B
$13.5M 1.48%
228,528
-878,000
-79% -$43.5M
PANW icon
18
Palo Alto Networks
PANW
$270B
$13.4M 1.47%
144,000
-42,000
-23% -$3.63M
CCCC icon
19
C4 Therapeutics
CCCC
$385M
$12.8M 1.41%
398,469
+16,695
+4% +$660K
BURL icon
20
Burlington
BURL
$23.2B
$12.1M 1.33%
+41,501
New +$11.7M
CRNX icon
21
Crinetics Pharmaceuticals
CRNX
$8.84B
$12M 1.32%
423,248
-125,395
-23% -$3.09M
FIVN icon
22
FIVE9
FIVN
$2.11B
$11.7M 1.29%
+85,556
New +$12.7M
KURA icon
23
Kura Oncology
KURA
$800M
$11.7M 1.28%
832,238
+43,503
+6% +$705K
ALT icon
24
Altimmune
ALT
$552M
$11.4M 1.25%
1,244,241
+155,387
+14% +$1.65M
FATE icon
25
Fate Therapeutics
FATE
$286M
$10.9M 1.19%
185,476
-33,823
-15% -$1.92M
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sphera Funds Management held 141 positions worth $910M, down 24% from $1.19B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Sphera Funds Management withdrew a net $283M in Q4 2021, closing 51 positions and reducing 31 holdings. Its most notable exit was SolarEdge, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Merck worth $26.6M.

  • Sphera Funds Management's largest Q4 2021 buy was Merck: 346,423 shares worth $26.6M.
  • Sphera Funds Management added most to Amazon in Q4 2021, an estimated $13.8M increase.
  • Sphera Funds Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $47.9M.
  • Sphera Funds Management fully exited SolarEdge in Q4 2021, selling an estimated $13.3M.
  • Sphera Funds Management's ten largest holdings make up 41% of its $910M portfolio in Q4 2021.
  • Sphera Funds Management opened 25 new positions and closed 51 in Q4 2021.
  • Sphera Funds Management's portfolio value fell 24% quarter-over-quarter to $910M.

Based on Sphera Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.